Colucid Pharmaceuticals, Inc.

Shoucheng Du

James F White

Jeroen Cunera Verheijen

Kazumi Shiosaki

Daniel Coughlin

J David Leander

Nadia M J Rupniak

Compounds that inhibit cholinesterase activity and, upon hydrolysis release a pharmacologically active agent. The compounds of the invention are employed in methods to treat an individual. The pharmacologically active agent obtained by hydrolysis of the compound can treat, for example, a nervous system condition, a cholinergic deficiency and conditions or diseases associated with a deficiency in a pharmacologically active agent, such as acetylcholine.

Compounds that inhibit cholinesterase

Carbamoyl esters inhibit cholinesterase activity and, upon hydrolysis release a pharmacologically active agent. In one embodiment, the carbamoyl ester has the following structure: Formula (I) wherein A is selected from the group consisting of an unsubstituted aryl, a substituted aryl, an unsubstituted heteroaryl and a substituted heteroaryl. The carbamoyl esters are employed in methods to treat an individual. The pharmacologically active agent obtained by hydrolysis of the carbamoyl esters can treat, for example, a nervous system condition, a cholinergic deficiency and conditions or diseases associated with a deficiency in a pharmacologically active agent, such as acetylcholine. 

Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents

Growing community of inventors

Pittsburgh, PA, United States of America

Shoucheng Du